
Sertaconazole (2% w/v) + Mometasone (0.1% w/v)
Active composition
+1 more active ingredient
Sertaconazole inhibits the synthesis of ergosterol, a key component of fungal cell membranes, leading to cell death.
Mometasone inhibits the release of pro-inflammatory cytokines and mediators, reducing inflammation and immune response.
Medical applications
Onabet SD Solution is a topical pharmaceutical formulation containing Sertaconazole nitrate (2% w/v) and Mometasone furoate (0.1% w/v), designed for the treatment of inflammatory and fungal skin conditions. Sertaconazole is a broad-spectrum antifungal agent belonging to the imidazole class, exhibiting potent activity against dermatophytes, yeasts, and molds by inhibiting ergosterol synthesis, thereby disrupting fungal cell membrane integrity. Mometasone furoate is a potent corticosteroid with anti-inflammatory, antipruritic, and vasoconstrictive properties, effectively reducing inflammation, redness, and itching associated with various dermatoses. The combination of Sertaconazole and Mometasone provides a synergistic effect, addressing both fungal infection and the accompanying inflammatory response. Onabet SD Solution is indicated for the management of superficial mycoses such as tinea corporis, tinea cruris, and candidiasis, especially when inflammation and pruritus are prominent. The solution formulation allows for easy application and rapid absorption, enhancing patient compliance. Caution is advised in patients with hypersensitivity to any component, and prolonged use should be avoided to minimize potential corticosteroid-related adverse effects. Onabet SD Solution should be used under medical supervision, adhering to prescribed dosage and duration to ensure optimal therapeutic outcomes.
Dosage information not available. Please consult your doctor or pharmacist.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Onabet SD Solution may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
High Risk
Onabet SD Solution should be used with caution during breastfeeding. Breastfeeding should be held until the treatment of the mother is completed and the drug is eliminated from her body.
Medical Advice
No interaction found/established
Exercise Caution
No interaction found/established
Consult Doctor
No interaction found/established
Regular Checkup
0 reviews for Onabet SD Solution

Sertaconazole (2% w/v) + Mometasone (0.1% w/v)
Cheaper alternative availability
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
Active composition
+1 more active ingredient
Sertaconazole inhibits the synthesis of ergosterol, a key component of fungal cell membranes, leading to cell death.
Mometasone inhibits the release of pro-inflammatory cytokines and mediators, reducing inflammation and immune response.
Medical applications
Onabet SD Solution is a topical pharmaceutical formulation containing Sertaconazole nitrate (2% w/v) and Mometasone furoate (0.1% w/v), designed for the treatment of inflammatory and fungal skin conditions. Sertaconazole is a broad-spectrum antifungal agent belonging to the imidazole class, exhibiting potent activity against dermatophytes, yeasts, and molds by inhibiting ergosterol synthesis, thereby disrupting fungal cell membrane integrity. Mometasone furoate is a potent corticosteroid with anti-inflammatory, antipruritic, and vasoconstrictive properties, effectively reducing inflammation, redness, and itching associated with various dermatoses. The combination of Sertaconazole and Mometasone provides a synergistic effect, addressing both fungal infection and the accompanying inflammatory response. Onabet SD Solution is indicated for the management of superficial mycoses such as tinea corporis, tinea cruris, and candidiasis, especially when inflammation and pruritus are prominent. The solution formulation allows for easy application and rapid absorption, enhancing patient compliance. Caution is advised in patients with hypersensitivity to any component, and prolonged use should be avoided to minimize potential corticosteroid-related adverse effects. Onabet SD Solution should be used under medical supervision, adhering to prescribed dosage and duration to ensure optimal therapeutic outcomes.
Dosage information not available. Please consult your doctor or pharmacist.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Onabet SD Solution may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
High Risk
Onabet SD Solution should be used with caution during breastfeeding. Breastfeeding should be held until the treatment of the mother is completed and the drug is eliminated from her body.
Medical Advice
No interaction found/established
Exercise Caution
No interaction found/established
Consult Doctor
No interaction found/established
Regular Checkup
0 reviews for Onabet SD Solution















